AbGenomics International Receives $9,600,000 New Financing

  • Feed Type
  • Date
    7/19/2013
  • Company Name
    AbGenomics International
  • Mailing Address
    4984 El Camino Real Los Altos, CA 94022
  • Company Description
    AbGenomics International Inc., incorporated in Delaware with principal office in San Francisco Bay Area, California, is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
  • Website
    http://www.abgenomics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    AbGenomics will use the proceeds to continue advancing its therapeutic antibodies for autoimmune diseases and cancers.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.